Statements (60)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:cause |
gptkb:Influenza
|
gptkbp:characteristics |
Enveloped virus
Negative-sense RNA Segmented RNA genome |
gptkbp:community_health |
Vaccination campaigns
Surveillance programs Outbreak response |
gptkbp:community_impact |
Annual epidemics
Significant morbidity and mortality |
gptkbp:complications |
gptkb:Pneumonia
Bronchitis Sinus infections Worsening of chronic conditions |
gptkbp:diagnosis |
PCR test
Rapid influenza diagnostic tests |
gptkbp:diseases |
Seasonal outbreaks
|
gptkbp:duration |
5 to 7 days
|
gptkbp:family |
gptkb:Orthomyxoviridae
|
gptkbp:genetic_studies |
Antigenic drift
Antigenic shift |
gptkbp:genus |
gptkb:Influenzavirus
|
gptkbp:hosts |
gptkb:Pigs
gptkb:birds gptkb:humans |
https://www.w3.org/2000/01/rdf-schema#label |
Influenza virus
|
gptkbp:incubation_period |
1 to 4 days
|
gptkbp:is_monitored_by |
WHO Global Influenza Surveillance and Response System
National Influenza Centers |
gptkbp:is_vulnerable_to |
Varies by season
Live attenuated vaccine Inactivated vaccine Depends on match with circulating strains Recombinant vaccine |
gptkbp:pandemic |
gptkb:2009_H1_N1_pandemic
|
gptkbp:prevention |
Vaccination
Hand hygiene Avoiding close contact |
gptkbp:research |
Vaccine development
Viral evolution Antiviral resistance |
gptkbp:risk_management |
Elderly
Young children Pregnant women Individuals with chronic health conditions |
gptkbp:seasonal_activities |
Winter months
|
gptkbp:symptoms |
gptkb:Fever
gptkb:Cough Fatigue Sore throat Muscle aches |
gptkbp:transmission |
Airborne droplets
|
gptkbp:treatment |
Antiviral medications
|
gptkbp:treatment_timing |
Early treatment recommended
|
gptkbp:type_of |
gptkb:Skin
gptkb:H1_N1 gptkb:H3_N2 gptkb:B/_Victoria |
gptkbp:bfsParent |
gptkb:Orthomyxovirinae
|
gptkbp:bfsLayer |
6
|